News
Eli Lilly's new oral weight-loss pill, orforglipron, shows promise in late-stage trials across countries like India and the ...
A new drug, called orforglipron, can help people with diabetes manage their A1C and weight, according to topline results from ...
When it comes to oral semaglutide, the OASIS-1 trial showed that it led to a 15.1% reduction in body weight. But this was at ...
A Kentucky doctor faces up to three years in prison after admitting he sold patients a non-approved weight-loss drug.
The first GLP-1 weight-loss pill is a step closer to hitting the market. Eli Lilly said its experimental pill met its goals ...
A new oral GLP-1 drug candidate could transform the diabetes and weight loss drug boom. Why it matters: Eli Lilly said on ...
Drugmaker Eli Lilly said Thursday that an experimental pill form of popular GLP-1 medications helped people with type 2 diabetes lose an average<a class="excerpt-read-more" href=" More ...
Eli Lilly reported promising results from a study of its experimental oral drug that could rival popular injections to treat ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results